Improvement of Fluid Balance in Patients Undergoing Surgery of the Colon and Rectum
NCT ID: NCT01175317
Last Updated: 2014-06-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
58 participants
INTERVENTIONAL
2010-04-30
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that the intervention group will have less intestinal damage, improved blood supply to the bowel and improved recovery of the operation compared to the control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes
NCT01563991
The Change in RetHe - Levels Perioperatively in a Cohort of Colorectal Surgery Patient
NCT03500497
Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment
NCT05353127
Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage
NCT05250882
Effect of General Anesthesia and Mechanical Ventilation on Plasma Metabolite in Patient With Colorectal Cancer Resection
NCT03137628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Goal-directed fluid optimization
Fluid administration and optimization based on cardiac output findings during surgery and during the first 8 hours of the postoperative phase.
Goal-directed fluid optimization
Fluid administration and optimization based on cardiac output findings during surgery and during the first 8 hours of the postoperative phase.
Regimen based on expertise anaesthesist
Fluid regimen based on expertise anaesthesist
Regimen based on expertise anaesthesist
Fluid regimen based on expertise anaesthesist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Goal-directed fluid optimization
Fluid administration and optimization based on cardiac output findings during surgery and during the first 8 hours of the postoperative phase.
Regimen based on expertise anaesthesist
Fluid regimen based on expertise anaesthesist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum age 18 years;
* Giving informed consent.
Exclusion Criteria
* Steroid use;
* Esophageal varices and other esophageal disease;
* Aortic valve disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maarten F Von Meyenfeldt, MD, PhD
Role: STUDY_DIRECTOR
Maastricht University Medical Center
Martijn Poeze, MD, PhD
Role: STUDY_DIRECTOR
Maastricht University Medical Center
Geerard L Beets, MD, PhD
Role: STUDY_DIRECTOR
Maastricht University Hospital
Wim A Buurman, PhD
Role: STUDY_DIRECTOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Maastricht
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEC 09-2-089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.